In vivo activity has also been demonstrated for one of the compounds using a simple infection model, the nematode Caenorhabditis elegans. Importantly, this also showed that the compound tested was not toxic to the nematodes.
Introduction
Multidrug resistant bacteria such as methicillin-resistant Staphylococcus aureus (MRSA) or extended spectrum beta lactamase (ESBL) producing Escherichia coli are a significant problem in modern healthcare (Karageorgopoulos and Falagas, 2009) . Resistance against antimicrobial agents develops quickly, even against synthetic compounds that bacteria have never encountered previously (Tsiodras et al., 2001) . There is therefore a real need to continuously look for new types of antibacterial compounds. Several avenues are being followed to find new compounds that inhibit growth or virulence of pathogenic bacteria. One type of compound that has not been studied in great detail are metal complexes. Some early studies showed activity of metal chelates against a range of Gram-negative and Gram-positive bacteria (Dwyer et al., 1952; Dwyer et al., 1969) .
In infection models using rodents these compounds showed promise in particular in the topical treatment of bacterial infections (Dwyer et al., 1969) . Other studies have shown that platinum-containing complexes have antibacterial activity. These are, however, quite toxic to eukaryotic cells, and compounds such as cisplatin are now mainly used in the treatment of cancer (Boulikas and Vougiouka, 2003) . We recently showed that a major groove binder, a dinuclear iron(II) supramolecular helicate, has activity against Gram-positive bacteria (Richards et al., 2009) . In that case it was also demonstrated that the helicate was able to bind to the chromosomal DNA of bacteria, but it was not clear whether it was DNA-binding alone that that lead to its bactericidal activity. Barton, 1985; Eriksson et al., 1994; Hiort et al., 1993; Rehmann and Barton, 1990 , and references therein).
These studies have shown that phen (1,10-phenanthroline) as the intercalating ligand is amongst the weakest moieties capable of any extent of intercalation. When the intercalating ligand is dppz (dipyrido[3,2-a:2'3'-c]phenazine), the complex has much higher affinity for DNA due to the greatly increased overlap of the extended phenazine rings with the aromatic bases of nucleic acids. 
Materials and Methods

Strains and growth conditions
The bacterial strains used in this study are Escherichia coli MC4100 (Peters et al., 2003) ,
Bacillus subtilis 168 (Kunst et al., 1997) , Enterococcus faecalis BS385 (van Merode et al., 2006) , Enterococcus faecium E1162 (Heikens et al., 2007) , and Staphylococcus aureus MRSA252, MRSA41 and MSSA160 (Feil et al., 2003) . Strains were maintained on LuriaBertani (LB) broth (Fisher) or Brain Heart Infusion (BHI) broth (Fisher).
Synthesis of Ru(II) complexes
[Ru(phen) 2 (dpq)]Cl 2 (Greguric et al., 1997) , [Ru(bpy) 2 (dpqC)](PF 6 ) 2 (Collins et al., 1998) , and [Ru(2,9-Me 2 phen) 2 (dppz)]Cl 2 (Greguric et al., 2000) were synthesised and characterised as previously described. In all cases racemic mixtures were used in this work.
Disc susceptibility tests
Mueller-Hinton (MH; Fisher) agar plates were seeded with approximately 10 5 bacteria. Discs (Whatmann 3MM chromatography paper, 6 mm) impregnated with 30 µg compound were applied to these plates. As negative controls discs with solvent only (dimethyl sulfoxide) were applied, all of which gave no zone of inhibition. Plates were incubated for 18 hours at 37 o C and the diameter of the clearing zone around the discs was measured.
Minimal inhibitory concentration and minimal bactericidal concentration
The MIC (minimal inhibitory concentration) values were determined with a macrobroth dilution method using MH broth as previously described (Andrews, 2001) . MBC (minimal bactericidal concentration) values were determined by plating 10 µL of each of the broth cultures from the MIC tests and incubating those plates at 37 o C for 24 hours; the MBC was defined as the lowest concentration at which no growth was observed.
Time-kill assays
Cells were grown to mid-exponential growth phase in MH broth and then diluted to give a final concentration of approximately 10 6 cells per mL. Compound was added and samples were taken at regular intervals. To remove the compound, cells were immediately collected by centrifugation (2 min at 14,000 g) and washed with fresh medium. The viable count was determined by plating serial dilutions, and the number of colony forming units (CFU) per mL was calculated.
C. elegans rescue and toxicity assays
For nematode infection and rescue assays, a strain that is hypersensitive to pathogens was used, Caenorhabditis elegans glp-4(bn2) sek-1(km4) (Moy et al., 2006) . The strain, which was obtained from the Caenorhabditis Genetics Centre (CGC) at the University of Minnesota, also has a mutation leading to temperature-sensitive sterility so that it does not produce any progeny during the assay -this simplified the scoring of survival rates. For normal growth nematodes were maintained at 15 o C on nematode growth medium, using E. coli OP50 as a source of food (Brenner, 1974) . For infection, C. elegans worms were age-synchronised by isolating eggs through treatment with hypochlorite/NaOH and hatching the eggs overnight in 
Antibacterial activity in C. elegans
C. elegans is a soil nematode that feeds on bacteria. It has been shown to be a useful infection model for several human pathogens (for a recent review, see O'Callaghan and Vergunst, 2010) . It has been shown that virulent strains of S. aureus kill C. elegans through colonization of the gut, but if exposure to the bacteria is limited to less than 8 hours then the lifespan of the nematodes is normal (Sifri et al., 2003) . We therefore tested the ability of the most active complex in the in vitro screens, [Ru(2,9-Me 2 phen) 2 (dppz)] 2+ , to rescue C. elegans from S. aureus infection. In the assay the nematodes were exposed for 1 hour to S. aureus cells after which different concentrations of [Ru(2,9-Me 2 phen) 2 (dppz)] 2+ were added. As shown in Fig.   3 , without compound all nematodes died within 6 days. Addition of 1 mg/L compound, which is below the MIC value, somewhat improved the rate of survival after 3 to 4 days, but at longer times of incubation the survival rate was not improved. By way of contrast, when either 8 or 32 mg/L [Ru(2,9-Me 2 phen) 2 (dppz)] 2+ was added nearly 80% of worms were still alive after 6 days. That percentage was similar to the survival of worms not exposed to S.
aureus and metal complex (data not shown), showing that [Ru(2,9-Me 2 phen) 2 (dppz)] 2+ is not toxic to C. elegans. Notably, we also tested toxicity of the compounds towards C. elegans in the presence of their normal food (E. coli OP50). Even at the highest concentration of 128 µg/ml the nematodes appeared not to be affected for at least 72 hours, and survival rates with or without compounds were identical (data not shown).
Discussion
S. aureus MRSA252 belongs to a clinically significant clone that is important for a large proportion of MRSA outbreaks in many countries, including the UK and the USA (Holden et al., 2004) . It is resistant against several antibiotics, yet we show here that this strain and two other S. aureus isolates are sensitive to the Ru(II) complexes assayed in this work, with the most effective compound being [Ru(2,9-Me 2 phen) 2 (dppz)] 2+ . These complexes were not active against E. coli; it is conceivable that they are, for instance, not able to cross the outer membrane of E. coli, but further experiments need to be performed in order to test this.
The time to kill S. aureus with [Ru(2,9-Me 2 phen) 2 (dppz)] 2+ was relatively fast as compared to some antibiotics that are used for the treatment of S. aureus infections. For instance, vancomycin has been shown to require 24 hours to kill 99.9% of S. aureus cells at a concentration of 4 × MBC (Murillo et al., 2006) . The time we observed for [Ru(2,9-Me 2 phen) 2 (dppz)] 2+ to act is more comparable with e.g. quinolones such as levofloxacin or ciprofloxacin, which at similar concentrations require around 4 hours to reach 99.9% kill (Murillo et al., 2006; Gosbell, 2006) .
Considering only the intercalating ligands of the three ruthenium complexes tested, the antibacterial activity was in the order dppz>dpqC>dpq. This is also the order of their DNA-binding affinity, with dppz having the highest affinity and dpq the lowest (Delaney et al., 2002) . This is consistent with the antibacterial activity of the Ru complexes being governed by their DNA-binding characteristics. (Liu et al., 2001) . A straightforward correlation between affinity and antimicrobial activity is therefore difficult to make. The reason for this may be that uptake in bacteria or binding to other targets such as proteins or ribosomes may also play a role.
In addition to the in vitro studies, we have shown that [Ru(Me 2 phen) 2 (dppz)] 2+ is active in vivo as it prevented death of C. elegans nematodes infected with S. aureus.
Importantly, the compound was also not toxic to C. elegans, which is a good indicator that they are also not toxic in higher eukaryotes (Leung et al., 2008) . It needs to be pointed out,
however, that we have not tested the compounds against mammalian cell cultures and it is clear that further tests are necessary to confirm that the Ru(II) complexes are not cytotoxic. It is nevertheless worth noting that, although C. elegans is a very simple model system, it does share several features with higher animals and has neurons, muscles, intestines, epidermis, and an innate immune response system (Artal-Sanz et al., 2006) . C. elegans has been shown to be very valuable in antimicrobial drug discovery, as exemplified in studies on E. faecalis and Candida albicans (Moy et al., 2006; Okoli et al., 2009) . Whether the Ru(II) complexes tested here will indeed be a starting point for the development of compounds appropriate for clinical use will require further investigation by analysing their toxicity, uptake, and mode of action. b ND, not determined as the strains indicated were resistant to the compound in the disc tests. 
